Clinical Trials Browser

Prostatic Neoplasms × Immunotherapy × Clear all

NCT07250542 2025-11-26

A Clinical Study on the Efficacy and Safety of Fasudil Hydrochloride Combined With Immunotherapy in the Treatment of Metastatic Castration-resistant Prostate Cancer

Phase 2 Recruiting

Prostatic Neoplasms

NCT00089856 2008-11-05

GVAX® Vaccine for Prostate Cancer vs Docetaxel & Prednisone in Patients With Metastatic Hormone-Refractory Prostate Cancer

Phase 3 Terminated

Neoplasm Metastasis, Neoplasms, Prostatic Neoplasms